35
Participants
Start Date
March 20, 2017
Primary Completion Date
June 4, 2018
Study Completion Date
June 4, 2018
0.075mg/kg TT301/MW189
0.075 mg/kg IV twice daily on Days 1 through 5
0.15mg/kg TT301MW189
0.15 mg/kg IV twice daily on Days 1 through 5
0.25mg/kg TT301/MW189
0.25 mg/kg IV twice daily on Days 1 through 5
0.30mg/kg TT301/MW189
0.30 mg/kg IV twice daily on Days 1 through 5
Placebo
0.9% sodium chloride
Duke Clinical Research Unit 40 Duke Medicine Circle, Durham
Collaborators (1)
Duke Clinical Research Institute
OTHER
Alzheimer's Association
OTHER
Linda Van Eldik
OTHER